Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat

Acta Physiologica Scandinavica

Volumn 165, Issue 1, 1999, Pages 15-23

  Bergdahl, A ^a,c   Valdemarsson, S ^a   Nilsson, T ^a   Sun, X Y ^b   Hedner, T ^b   Edvinsson, L ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acetylcholine; Calcitonin gene related peptide; Congestive heart failure; Dilatation; Substance P

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIET; ILIAC VEIN; LEFT CORONARY ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY;

EID: 0032958759     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201x.1999.00456.x     Document Type: Article

References (32)

1. Anand, I.S., Gurden, J., Wander, G.S., et al. 1991. Cardiovascular and hormonal effects of calcitonin gene-related peptide in congestive heart failure. J Am Coll Cardiol 17, 208-217.
2. Angus, J.A. 1996. Role of the endothelium in the genesis of cardiovascular disease. Clin Exp Pharm Physiol 23, S16-S22.
3. Angus, J.A., Ferrier, C.P., Sudhir, K., Kaye, D.M. & Jennings, G.L. 1993. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc Res 27, 204-210.
4. Arnal, J.-F., Schott, C., Stoclet, J.-C. & Michel, J.-B. 1993. Vascular relaxation and cyclic guanosine monophosphate in a rat model of high output heart failure. Cardiovasc Res 27, 1651-1656.
5. Bergdahl, A., Valdermansson, S., Pantev, E., et al. 1995. Modulation of vascular contractile responses to α1-and α2-adrenergic and neuropeptide Y receptor stimulation in rats with ischemic heart failure. Acta Physiol Scand 154, 429-437.
6. 2α in heart failure. Am Heart J 133, 94-100.
7. Drexler, H., & LU, W. 1992. Endothelial dysfunction of hindquarter resisitance vessels in experimental heart failure. Am J Physiol 262, H1640-H1645.
8. Drexler, H., Hablawetz, E., LU, W., Riede, U. & Christes, A. 1992a. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation 86, 255-262.
9. Drexler, H., Hayoz, D., Münzel, T., et al. 1992b. Endothelial function in chronic congestive heart failure. Am J Cardiol 69, 1596-1601.
10. Elsner, D., Müntze, A., Kromer, E.P. & Riegger, G.A.J. 1991. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res 25, 438-440.
11. Ferrari, R., Panzali, A.F., Poole-Wilson, P.A. & Anand, I.S. 1991. Plasma CGRP-like immunoreactivity in treated and untreated congestive heart failure. Lancet 338, 1084.
12. Forster, C. & Armstrong, P.W. 1990. Pacing induced heart failure in the dog: Evaluation of peripheral vascular alpha adrenoceptor subtypes. J Cardiovasc Res 16, 708-718.
13. Forster, C., Campell, P.M. & Armstrong, P.W. 1992. Temporal alterations in peripheral vascular responsiveness during both the development and recovery from pacing-induced heart failure. J Cardiovasc Pharmacol 20, 206-215.
14. Gennari, C., Nami, R., Agnusdei, D. & Fischer, J.A. 1990. Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure. Cardiovasc Res 24, 239-241.
15. Helin, K., Tikkanen, I., Kiilavuori, K., Naveri, H. & Fyhrquist, F. 1994. Calcitonin gene related peptides is not elevated in rat plasma by heart failure or by neutral endopeptidase inhibition. Life Sci 55, 471-477.
16. Hirooka, Y., Imaizumi, T., Harada, S., et al. 1992. Endothelium-dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure. J Cardivasc Pharmacol 20, S221-S225.
17. Hirooka, Y., Imaizumi, T., Tagawa, T., et al. 1994. Effects of L-Arginine on impaired Acetylcholine-induced and iscemic vasodilation of the forearm in patients with heart failure. Circulation 90, 658-668.
18. Katz, S.D., Schwarz, M., Yuen, J. & Lejemtel, T. H. 1993. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88, 55-61.
19. Kubo, S., Rector, T.S., Bank, A.J., Williams, R.E. & Heifetz, S.M. 1991. Endothelium-dependent vasodilatation is attenuated in patients with heart failure. Circulation 84, 1589-1596.
20. Lindsay, D.C., Holdright, D.R., Clarke, D., Anand, I.S., Poole-Wilson, P.A. & Collins, P. 1996. Endothelial control of lower limb blood flow in chronic heart failure. Heart 75, 469-476.
21. Lindsay, D.C., Jiang, C., Brunotte, F., et al. 1992. Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res 26, 694-697.
22. Love, M.P. & McMurray, J.J.V. 1996. Endothelin in chronic heart failure: current position and future prospects. Cardiovasc Res 31, 665-674.
23. Main, J.S., Forster, C. & Armstrong, P.W. 1991. Inhibitory role of the coronary arterial endothelium to alpha-adrenergic stimulation in experimental heart failure. Circ Res 68, 940-946.
24. Pfeffer, M.A., Pfeffer, J.M., Fishbein, M.C., et al. 1979. Myocardial infarct size and ventricular function in rats. Circ Res 44, 503-512.
25. Plane, F. & Garland, C.J. 1996. Influence of contractile agonists on the mechanism of endothelium-dependent relaxation in rat isolated mesenteric artery. Br J Pharmacol 119, 191-193.
26. Rubinstein, G., Müns, G. & Zucker, I.H. 1994. Plasma exsudation in conscious dogs with experimental heart failure. Bas Res Cardiol 89, 487-498.
27. Shekhar, Y.C., Anand, I.S., Sarma, R., Ferrari, R., Wahi, P.L. & Poole-Wilson, P.A. 1991. Effects of prolonged infusion of human alpha calcitonin gene related peptide on haemodynamics, renal blood flow and hormone levels in congestive heart failure. Am J Cardiol 67, 732-736.
28. Smith, C.J., Sun, D., Hoegler, C., et al. 1996. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 78, 58-64.
29. Taquet, H., Komajda, M., Grenier, O., et al. 1992. Plasma calcitonin gene related peptide decreases in chronic congestive heart failure. Eur Heart J 13, 1473-1476.
30. Teerlink, J.R., Clozel, M., Fischli, W. & Clozel, J.P. 1993. Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol 22, 615-620.
31. Teerlink, J.R., Gray, G.A., Clozel, M. & Clozel, J.-P. 1994. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Circulation 89, 393-401.
32. Valdemarsson, S., Bergdahl, A. & Edvinsson, L. 1994. Relationships between plasma levels of catecholamines and neuropeptides and the survival time in patients with congestive heart failure. L Int Med 235, 595-601.